Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P De Deyn

Showing results (191-200 of 493) with videos related to

Pageof 50
Sort By:
Clinical Neurology and Neurosurgery|August 25, 2011
Prevalence and incidence of dementia among 75-80-year-old community-dwelling elderly in different districts of Antwerp, Belgium: the Antwerp Cognition (ANCOG) StudyP P De Deyn, J Goeman, A Vervaet, et al.
Neurochemistry International|May 28, 2010
Subcellular distribution and axonal transport of noradrenaline, dopamine-?-hydroxylase and neuropeptide Y in dog splenic nerveP P De Deyn, B A Pickut, A Verzwijvelen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2012
Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementiaYannick Vermeiren, Nathalie Le Bastard, An Van Hemelrijck, et al.
European Neurology|January 1, 1991
Slow progressive bilateral posterior artery infarction presenting as agitated delirium, complicated with Anton's syndromeW Verslegers, P P De Deyn, J Saerens, et al.
The European Journal of Neuroscience|January 25, 2003
Age-dependent cognitive decline in the APP23 model precedes amyloid depositionDebby Van Dam, Rudi D'Hooge, Matthias Staufenbiel, et al.
Frontiers in Neurology|July 3, 2015
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia DiagnosisHanne Struyfs, Ellis Niemantsverdriet, Joery Goossens, et al.
Human Gene Therapy|June 12, 2001
Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cellsU Matzner, F Schestag, D Hartmann, et al.
Arzneimittel-Forschung|June 1, 1996
Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonistsR D'Hooge, Y Q Pei, A Raes, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 20, 2018
Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosisJana Janssens, Yannick Vermeiren, Erik Fransen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2006
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stressD Aarsland, K Brønnick, U Ehrt, et al.
Pageof 50

Showing results (191-200 of 493) with videos related to

Sort By:
Pageof 50
Clinical Neurology and Neurosurgery|August 25, 2011
Prevalence and incidence of dementia among 75-80-year-old community-dwelling elderly in different districts of Antwerp, Belgium: the Antwerp Cognition (ANCOG) StudyP P De Deyn, J Goeman, A Vervaet, et al.
Neurochemistry International|May 28, 2010
Subcellular distribution and axonal transport of noradrenaline, dopamine-?-hydroxylase and neuropeptide Y in dog splenic nerveP P De Deyn, B A Pickut, A Verzwijvelen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2012
Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementiaYannick Vermeiren, Nathalie Le Bastard, An Van Hemelrijck, et al.
European Neurology|January 1, 1991
Slow progressive bilateral posterior artery infarction presenting as agitated delirium, complicated with Anton's syndromeW Verslegers, P P De Deyn, J Saerens, et al.
The European Journal of Neuroscience|January 25, 2003
Age-dependent cognitive decline in the APP23 model precedes amyloid depositionDebby Van Dam, Rudi D'Hooge, Matthias Staufenbiel, et al.
Frontiers in Neurology|July 3, 2015
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia DiagnosisHanne Struyfs, Ellis Niemantsverdriet, Joery Goossens, et al.
Human Gene Therapy|June 12, 2001
Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cellsU Matzner, F Schestag, D Hartmann, et al.
Arzneimittel-Forschung|June 1, 1996
Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonistsR D'Hooge, Y Q Pei, A Raes, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 20, 2018
Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosisJana Janssens, Yannick Vermeiren, Erik Fransen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2006
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stressD Aarsland, K Brønnick, U Ehrt, et al.
Pageof 50